Working…
ClinicalTrials.gov
ClinicalTrials.gov Menu

Clinical Study to Assess the Safety, Tolerability and Efficacy of Macitentan in Subjects With Inoperable Chronic Thromboembolic Pulmonary Hypertension (MERIT-2)

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
 
ClinicalTrials.gov Identifier: NCT02060721
Recruitment Status : Active, not recruiting
First Posted : February 12, 2014
Last Update Posted : April 14, 2021
Sponsor:
Information provided by (Responsible Party):
Actelion

No Study Results Posted on ClinicalTrials.gov for this Study
Recruitment Status : Active, not recruiting
Estimated Primary Completion Date : December 22, 2021
Estimated Study Completion Date : December 22, 2021